인공 췌장 시장(2026-2030년)

The global artificial pancreas market is forecasted to grow by USD 583.1 mn during 2025-2030, accelerating at a CAGR of 18.3% during the forecast period. The report on the global artificial pancreas market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of remote patient monitoring, shift toward preventive chronic care, growing patient preference for automation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global artificial pancreas market is segmented as below:

By Type

• Threshold suspend device
• Non-threshold suspend device
• Control to range system
• Control to target system

By End-User

• Hospitals
• Home care
• Specialty clinics
• Ambulatory surgical centers

By Indication

• Type 1 diabetes
• Type 2 diabetes
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rise of advanced closed loop systems as one of the prime reasons driving the global artificial pancreas market growth during the next few years. Also, expansion of interoperable software platforms and integration of ai analytics will lead to sizable demand in the market.

The report on the global artificial pancreas market covers the following areas:

• Global artificial pancreas market sizing
• Global artificial pancreas market forecast
• Global artificial pancreas market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global artificial pancreas market vendors that include Abbott Laboratories, Ascensia Diabetes Care, Beta Bionics Inc., CamDiab Ltd., Dexcom Inc., Diabeloop SA, DreaMed Diabetes Ltd., Eoflow Co. Ltd., F. Hoffmann La Roche Ltd., Insulet Corp., Kaleido Diabetes Solutions Ltd., Medtronic Plc, Medtrum Technologies Inc., MicroTech MD, Senseonics Holdings Inc., Sequel Med Tech LLC, SOOIL Development Co. Ltd., Tandem Diabetes Care Inc., Terumo Corp., Ypsomed Holding AG. Also, the global artificial pancreas market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Indication
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Artificial Pancreas Market 2020 - 2024
  • Historic Market Size - Data Table on Global Artificial Pancreas Market 2020 - 2024 ($ million)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Indication segment analysis 2020 - 2024
  • Historic Market Size - Indication Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Artificial Pancreas Market
• 6.2 Impact of geopolitical conflicts on Global Artificial Pancreas Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Threshold suspend device - Market size and forecast 2025-2030
• 8.4 Non-threshold suspend device - Market size and forecast 2025-2030
• 8.5 Control to range system - Market size and forecast 2025-2030
• 8.6 Control to target system - Market size and forecast 2025-2030
• 8.7 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2025-2030
• 9.4 Home care - Market size and forecast 2025-2030
• 9.5 Specialty clinics - Market size and forecast 2025-2030
• 9.6 Ambulatory surgical centers - Market size and forecast 2025-2030
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Indication

• 10.1 Market segments
• 10.2 Comparison by Indication
• 10.3 Type 1 diabetes - Market size and forecast 2025-2030
• 10.4 Type 2 diabetes - Market size and forecast 2025-2030
• 10.5 Others - Market size and forecast 2025-2030
• 10.6 Market opportunity by Indication
  • Market opportunity by Indication ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Expansion of remote patient monitoring
  • Shift toward preventive chronic care
  • Growing patient preference for automation
• 13.2 Market challenges
  • High capital expenditure and reimbursement barriers
  • Complex regulatory approvals and compliance standards
  • Interoperability limitations and algorithmic precision constraints
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Rise of advanced closed loop systems
  • Expansion of interoperable software platforms
  • Integration of AI analytics

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Ascensia Diabetes Care
  • Ascensia Diabetes Care - Overview
  • Ascensia Diabetes Care - Product / Service
  • Ascensia Diabetes Care - Key offerings
  • SWOT
• 15.6 CamDiab Ltd.
  • CamDiab Ltd. - Overview
  • CamDiab Ltd. - Product / Service
  • CamDiab Ltd. - Key offerings
  • SWOT
• 15.7 Dexcom Inc.
  • Dexcom Inc. - Overview
  • Dexcom Inc. - Product / Service
  • Dexcom Inc. - Key news
  • Dexcom Inc. - Key offerings
  • SWOT
• 15.8 Diabeloop SA
  • Diabeloop SA - Overview
  • Diabeloop SA - Product / Service
  • Diabeloop SA - Key offerings
  • SWOT
• 15.9 DreaMed Diabetes Ltd.
  • DreaMed Diabetes Ltd. - Overview
  • DreaMed Diabetes Ltd. - Product / Service
  • DreaMed Diabetes Ltd. - Key offerings
  • SWOT
• 15.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.11 Insulet Corp.
  • Insulet Corp. - Overview
  • Insulet Corp. - Product / Service
  • Insulet Corp. - Key news
  • Insulet Corp. - Key offerings
  • SWOT
• 15.12 Kaleido Diabetes Solutions Ltd.
  • Kaleido Diabetes Solutions Ltd. - Overview
  • Kaleido Diabetes Solutions Ltd. - Product / Service
  • Kaleido Diabetes Solutions Ltd. - Key offerings
  • SWOT
• 15.13 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.14 Medtrum Technologies Inc.
  • Medtrum Technologies Inc. - Overview
  • Medtrum Technologies Inc. - Product / Service
  • Medtrum Technologies Inc. - Key offerings
  • SWOT
• 15.15 MicroTech MD
  • MicroTech MD - Overview
  • MicroTech MD - Product / Service
  • MicroTech MD - Key offerings
  • SWOT
• 15.16 Tandem Diabetes Care Inc.
  • Tandem Diabetes Care Inc. - Overview
  • Tandem Diabetes Care Inc. - Product / Service
  • Tandem Diabetes Care Inc. - Key offerings
  • SWOT
• 15.17 Terumo Corp.
  • Terumo Corp. - Overview
  • Terumo Corp. - Business segments
  • Terumo Corp. - Key news
  • Terumo Corp. - Key offerings
  • Terumo Corp. - Segment focus
  • SWOT
• 15.18 Ypsomed Holding AG
  • Ypsomed Holding AG - Overview
  • Ypsomed Holding AG - Business segments
  • Ypsomed Holding AG - Key offerings
  • Ypsomed Holding AG - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations